Low episodic memory performance in cognitively normal elderly subjects is associated with increased posterior cingulate gray matter N-acetylaspartate: a 1H MRSI study at 7 Tesla
暂无分享,去创建一个
Anke Henning | Lars Michels | Klaas P. Pruessmann | Adam M. Brickman | Roger M. Nitsch | Sandra E. Leh | Paul G. Unschuld | Michael Wyss | Thomas Kirchner | S. Leh | A. Brickman | K. Pruessmann | A. Henning | F. Quevenco | M. Wyss | S. Schreiner | Stefanie C. Steininger | Irene B. Meier | A. Gietl | R. Nitsch | C. Hock | P. Unschuld | L. Michels | T. Kirchner | Erica Y. Griffith | Frances C. Quevenco | Anton F. Gietl | Christoph Hock | J. V. Bergen | Simon J. Schreiner | Jiri M.G. Van Bergen | Irene Meier
[1] Claudius Mueller,et al. Longitudinal Metabolic and Cognitive Changes in Mild Cognitive Impairment Patients , 2008, Alzheimer disease and associated disorders.
[2] B. Meier,et al. Computer Simulations in Magnetic Resonance. An Object-Oriented Programming Approach , 1994 .
[3] Peter Boesiger,et al. Slice‐selective FID acquisition, localized by outer volume suppression (FIDLOVS) for 1H‐MRSI of the human brain at 7 T with minimal signal loss , 2009, NMR in biomedicine.
[4] G. Fein,et al. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. , 1996, Archives of neurology.
[5] F. Jessen,et al. Treatment monitoring and response prediction with proton MR spectroscopy in AD , 2006, Neurology.
[6] W. Bogner,et al. High‐resolution mapping of human brain metabolites by free induction decay 1H MRSI at 7 T , 2012, NMR in Biomedicine.
[7] Keith A. Johnson,et al. Functional Alterations in Memory Networks in Early Alzheimer’s Disease , 2010, NeuroMolecular Medicine.
[8] Cindee M. Madison,et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. , 2009, Brain : a journal of neurology.
[9] Nick C Fox,et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[10] D. Leibfritz,et al. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.
[11] P. Barker,et al. Single‐voxel proton MRS of the human brain at 1.5T and 3.0T , 2001, Magnetic resonance in medicine.
[12] T. Ernst,et al. Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease , 1994, Magnetic resonance in medicine.
[13] E G Tangalos,et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.
[14] Alexander Hammers,et al. Three‐dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe , 2003, Human brain mapping.
[15] C. Jack,et al. MRS in presymptomatic MAPT mutation carriers , 2010, Neurology.
[16] A. Dale,et al. Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.
[17] A. Picco,et al. Metabolic correlates of Rey auditory verbal learning test in elderly subjects with memory complaints. , 2014, Journal of Alzheimer's disease : JAD.
[18] Anke Henning,et al. Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype , 2015, Neurobiology of Aging.
[19] S. Leh,et al. Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects , 2014, Front. Aging Neurosci..
[20] B. Winblad,et al. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. , 2000, Archives of neurology.
[21] Stefan Teipel,et al. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer’s disease? , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[22] C. Elger,et al. Rey Auditory-Verbal Learning Test: structure of a modified German version. , 1997, Journal of clinical psychology.
[23] Terry E. Goldberg,et al. APOE Genotype Modulates Proton Magnetic Resonance Spectroscopy Metabolites in the Aging Brain , 2014, Biological Psychiatry.
[24] P. Matthews,et al. Distinct patterns of brain activity in young carriers of the APOE e4 allele , 2009, NeuroImage.
[25] M. Albert. Changes in cognition , 2011, Neurobiology of Aging.
[26] Dimitrios Kapogiannis,et al. Posteromedial cortex glutamate and GABA predict intrinsic functional connectivity of the default mode network , 2013, NeuroImage.
[27] D. Bonekamp,et al. Quantitation of NAA in the brain by magnetic resonance spectroscopy. , 2006, Advances in experimental medicine and biology.
[28] Jamie Near,et al. Spectral Quantification and Pitfalls in Interpreting Magnetic Resonance Spectroscopic Data: What To Look Out For , 2014 .
[29] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[30] Ravi S. Menon,et al. Imaging at high magnetic fields: initial experiences at 4 T. , 1993, Magnetic resonance quarterly.
[31] C. Gasparovic,et al. Decrease and recovery of N-acetylaspartate/creatine in rat brain remote from focal injury. , 2001, Journal of neurotrauma.
[32] J. Schneider,et al. Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.
[33] Keith A. Johnson,et al. Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia , 2009, Neuron.
[34] B. Hyman,et al. Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.
[35] V. Leirer,et al. Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.
[36] Ariane Fillmer,et al. Reduction of voxel bleeding in highly accelerated parallel 1H MRSI by direct control of the spatial response function , 2015, Magnetic resonance in medicine.
[37] C. Jack,et al. Biomarker Modeling of Alzheimer’s Disease , 2013, Neuron.
[38] R. Wu,et al. Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study , 2012, Neuroradiology.
[39] J. Morris,et al. The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals , 2008, Cerebral cortex.
[40] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[41] D. Head,et al. Amyloid Plaques Disrupt Resting State Default Mode Network Connectivity in Cognitively Normal Elderly , 2010, Biological Psychiatry.
[42] M. Buonocore,et al. MR spectroscopic studies of the brain in psychiatric disorders. , 2012, Current topics in behavioral neurosciences.
[43] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .
[44] M N Rossor,et al. MRS shows abnormalities before symptoms in familial Alzheimer disease , 2006, Neurology.
[45] Mark A Mintun,et al. Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. , 2009, Archives of neurology.
[46] Roberta F. White,et al. The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. , 2000, Archives of neurology.
[47] J. Moffett,et al. N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.
[48] Silke Lux,et al. Verbaler Lern- und Merkfähigkeitstest , 2001 .
[49] Rolf Gruetter,et al. MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T , 2009, Magnetic resonance in medicine.
[50] M W Weiner,et al. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging , 2001, Magnetic resonance in medicine.
[51] M. Giroud,et al. N‐Acetylaspartate: a literature review of animal research on brain ischaemia , 2004, Journal of neurochemistry.
[52] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.
[53] J. Frahm,et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.
[54] S. Black,et al. Memory impairments associated with hippocampal versus parahippocampal-gyrus atrophy: an MR volumetry study in Alzheimer’s disease , 1998, Neuropsychologia.
[55] C. Studholme,et al. Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI) , 2009, Magnetic resonance in medicine.
[56] J. Laczó,et al. Neuropsychological correlates of hippocampal atrophy in memory testing in nondemented older adults. , 2014, Journal of Alzheimer's disease : JAD.
[57] D. Selkoe,et al. The therapeutics of Alzheimer's disease: Where we stand and where we are heading , 2013, Annals of neurology.
[58] B D Ross,et al. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. , 1993, Radiology.
[59] S. Provencher. Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.
[60] Dimitrios Kapogiannis,et al. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease , 2011, The Lancet Neurology.
[61] A. Vezzani,et al. In vivo imaging of glia activation using 1H‐magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity , 2012, Epilepsia.
[62] Nick C Fox,et al. The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .
[63] T. Tombaugh. Trail Making Test A and B: normative data stratified by age and education. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.
[64] Elizabeth C Mormino,et al. Aβ Deposition in aging is associated with increases in brain activation during successful memory encoding. , 2012, Cerebral cortex.
[65] R. Reitan. Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .
[66] J. Clark,et al. N-Acetyl Aspartate: A Marker for Neuronal Loss or Mitochondrial Dysfunction , 1998, Developmental Neuroscience.
[67] D. Schacter,et al. The Brain's Default Network , 2008, Annals of the New York Academy of Sciences.
[68] Gina N. LaRossa,et al. [11C]PIB in a nondemented population , 2006, Neurology.
[69] K. Uğurbil,et al. In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T , 2009, Magnetic resonance in medicine.
[70] G L Shulman,et al. INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .
[71] Heinrich Lanfermann,et al. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy , 2009, Psychiatry Research: Neuroimaging.
[72] Paul Maruff,et al. β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease , 2007 .
[73] Bedda L. Rosario,et al. Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve , 2009, The Journal of Neuroscience.
[74] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[75] Jennifer Weuve,et al. Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia , 2015, Neurology.
[76] Benjamin J. Shannon,et al. Parietal lobe contributions to episodic memory retrieval , 2005, Trends in Cognitive Sciences.
[77] Daniel Rueckert,et al. Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest , 2008, NeuroImage.
[78] M. Greicius,et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.
[79] Nick C Fox,et al. The clinical use of structural MRI in Alzheimer disease , 2010, Nature Reviews Neurology.
[80] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[81] Wolfgang Grodd,et al. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases , 2003, Magnetic resonance in medicine.
[82] R. Lipton,et al. Memory impairment on free and cued selective reminding predicts dementia , 2000, Neurology.
[83] Patrizia Mecocci,et al. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy , 2006, Neurobiology of Aging.
[84] Peter B Barker,et al. Comparison of single voxel brain MRS AT 3T and 7T using 32-channel head coils. , 2015, Magnetic resonance imaging.
[85] Ariane Fillmer,et al. Constrained image‐based B0 shimming accounting for “local minimum traps” in the optimization and field inhomogeneities outside the region of interest , 2015, Magnetic resonance in medicine.
[86] Kaori Takehara-Nishiuchi,et al. The cortical structure of consolidated memory: A hypothesis on the role of the cingulate–entorhinal cortical connection , 2013, Neurobiology of Learning and Memory.
[87] Anders M. Dale,et al. Sequence-independent segmentation of magnetic resonance images , 2004, NeuroImage.
[88] N. Schuff,et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD , 2002, Neurology.
[89] R. Brookshire,et al. The Boston Naming Test: Revised Administration and Scoring Procedures and Normative Information for Non-Brain-Damaged Adults , 1989 .
[90] Hans Hoogduin,et al. High‐field MRS of the human brain at short TE and TR , 2011, NMR in biomedicine.
[91] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[92] Aaron Carass,et al. Brain metabolite alterations and cognitive dysfunction in early Huntington's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[93] R. Gruetter,et al. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time , 1999, Magnetic resonance in medicine.
[94] E. Kaplan,et al. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. , 1995, Archives of neurology.
[95] Roland Kreis,et al. The trouble with quality filtering based on relative Cramér‐Rao lower bounds , 2016, Magnetic resonance in medicine.
[96] F. Zang,et al. Role of Myo-Inositol by Magnetic Resonance Spectroscopy in Early Diagnosis of Alzheimer’s Disease in APP/PS1 Transgenic Mice , 2010, Dementia and Geriatric Cognitive Disorders.
[97] Paul Maruff,et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. , 2007, Brain : a journal of neurology.
[98] Alessio Fracasso,et al. FLAIR images at 7 Tesla MRI highlight the ependyma and the outer layers of the cerebral cortex , 2015, NeuroImage.
[99] A. Simmons,et al. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: A proton magnetic resonance spectroscopy study , 1997, Neurology.
[100] Brigitte Landeau,et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study , 2005, NeuroImage.
[101] J. Baron,et al. Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. , 2003, Brain : a journal of neurology.
[102] R. Sperling,et al. Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation , 2008, Proceedings of the National Academy of Sciences.
[103] J. Pettegrew,et al. N‐acetyl‐L‐aspartate and other amino acid metabolites in Alzheimer's disease brain , 1992, Neurology.
[104] L. Mosconi,et al. Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[105] Florence Pasquier,et al. Early diagnosis of dementia: neuropsychology , 1999, Journal of Neurology.
[106] A. Cavanna,et al. The precuneus: a review of its functional anatomy and behavioural correlates. , 2006, Brain : a journal of neurology.
[107] T. Goldberg,et al. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. , 2011, Archives of general psychiatry.
[108] C. Helmstaedter,et al. VLMT: Verbaler Lern- und Merkfähigkeitstest: Ein praktikables und differenziertes Instrumentarium zur Prüfung der verbalen Gedächtnisleistungen , 1990 .
[109] J. Mazziotta,et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[110] Eric M Reiman,et al. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. , 2007, Archives of neurology.
[111] Keith A. Johnson,et al. Preclinical Alzheimer disease—the challenges ahead , 2013, Nature Reviews Neurology.